Background: According to studies performed on terrestrial sports athletes, inspiratory muscle training (IMT) may improve athletes’ performance. However, evidence of its effects in elite swimmers is lacking. Therefore, we aimed to assess the effect of 12-week IMT on swimming performance, inspiratory muscle strength, lung function, and perceived breathlessness in elite swimmers. Methods: Elite swimmers from the main FC Porto swimming team (in competitive training for a minimum period of 3 years) were invited to participate and were randomly allocated into intervention or control groups. The intervention group performed 30 inspiratory efforts, twice a day, 5 times a week, against a pressure threshold load equivalent to 50% of maximal inspiratory pressure, whereas the control group performed inspiratory efforts at the same frequency but against a 15% load. Swimming performance was assessed through time trials, converted into points according to International Swimming Federation Points Table. Outcomes were evaluated before and following the 12-week study period. Results: A total of 32 participants (22 girls) were included. The median age was 15 and 14 years old for the intervention (n = 17) and control (n = 12) groups, respectively. No differences were found in swimming performance (P = .271), inspiratory muscle strength (P = .914), forced vital capacity (P = .262), forced expiratory volume in 1st second (P = .265), peak expiratory flow (P = .270), and perceived breathlessness (P = .568) between groups after 12 weeks of intervention. Conclusion: Twelve weeks of IMT had no effect on swimming performance, lung function, and perceived breathlessness in elite swimmers. These results may be related to swimming-specific factors and/or an applied load insufficient to achieve training overload that could induce further improvements.
Agranulocytosis is a severe haematological disorder with multiple aetiologies, among which drug-induced causes are clinically significant. Metamizole is a non-opioid analgesic and antipyretic agent, used for the management of severe pain and high fever unresponsive to other measures. However, its use remains controversial due to the risk of metamizole-induced agranulocytosis (MIA), a rare but potentially life-threatening adverse reaction. This case aims to raise clinical awareness of MIA, highlighting the importance of its cautious use in daily practice. To our knowledge, it provides valuable clinical insight given the rapid onset of severe agranulocytosis, absence of alternative causative factors, and successful recovery with early intervention.
8 January 2026 in European Journal of Case Reports in Internal Medicine
Background: Rhabdomyolysis (RM) is a multifactorial syndrome characterised by skeletal muscle breakdown and release of intracellular components, notably myoglobin, into the circulation. Elevated myoglobin levels are a major contributor to acute kidney injury (AKI), yet conventional renal replacement therapies (RRT) are limited in their ability to clear myoglobin due to its molecular size. Case description: We present a case of a woman who developed severe RM-induced AKI secondary to necrotising myopathy. Despite initial fluid and diuretic therapy, her condition progressed to oliguric AKI. She was admitted to intensive care unit and prolonged intermittent RRT was then initiated. Due to markedly elevated myoglobin levels, a haemoadsorption device (HA-380 hemoperfusion cartridge) was added to the RRT circuit, leading to significant laboratory and clinical improvement. Discussion: Severe RM frequently leads to AKI due to myoglobin-induced tubular damage. While conventional RRT removes myoglobin poorly, haemoadsorption using the HA-380 cartridge effectively reduced plasma myoglobin and creatine phosphokinase levels in our patient, supporting early implementation to enhance renal recovery. Evidence from case reports and recent studies suggests safety and efficacy, but clinical outcomes remain incompletely defined, and optimal therapy timing, thresholds and duration require further investigation. Conclusion: This case highlights the potential utility of extracorporeal adsorption therapy as an adjunct to RRT for effective myoglobin removal in severe RM-induced AKI. Early implementation of this strategy may enhance renal recovery and improve outcomes, though clinical evidence remains limited.